Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)

NCT07414667 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Central Hospital, Nancy, France